Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: Systematic review and economic evaluation

Health Technology Assessment

Volumn 13, Issue 17, 2009, Pages

  Simpson, E L ^a   Duenas, A ^a   Holmes, M W ^a   Papaioannou, D ^a   Chilcott, J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLYCERYL TRINITRATE; MORPHINE; NARCOTIC ANALGESIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SHORT ACTING DRUG;

ANALGESIA; ANGINA PAIN; ANGINA PECTORIS; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEVICE INFECTION; FAILED BACK SURGERY SYNDROME; FOREIGN BODY; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; NATIONAL HEALTH SERVICE; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REVIEW; RISK FACTOR; SPINAL CORD STIMULATION; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHRONIC DISEASE; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; ELECTROSTIMULATION THERAPY; EVIDENCE BASED MEDICINE; ISCHEMIA; METHODOLOGY; NEURALGIA; PROBABILITY; PSYCHOLOGICAL ASPECT; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY; SPINAL CORD; TREATMENT OUTCOME; UNITED KINGDOM;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DECISION TREES; ELECTRIC STIMULATION THERAPY; EVIDENCE-BASED MEDICINE; FAILED BACK SURGERY SYNDROME; GREAT BRITAIN; HUMANS; ISCHEMIA; MARKOV CHAINS; NEURALGIA; PAIN; PAIN MANAGEMENT; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFLEX SYMPATHETIC DYSTROPHY; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SPINAL CORD; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 65649126383     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13170     Document Type: Review

References (136)

1. Association for the Study of Pain. Classification of chronic pain. Pain 1986;Suppl 3:S1-S226.
2. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-52.
3. Ashburn MA, Staats PS. Management of chronic pain. Lancet 1999; 353:1865-9.
4. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definition of pain terms. Seattle: IASP Press; 1994.
5. Taylor RS. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/failed back surgery syndrome: results of a systematic review and meta-analysis. J Pain Symptom Manage 2006;31:S13-S19.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;33 Suppl. 1:S5-S67.
7. European Working Group on Critical Limb Ischaemia. Second European consensus document on chronic critical leg ischaemia. Circulation 1991;84 Suppl.:1-26.
8. ACC/AHA. 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2002;41:159-68.
9. The Criteria Committee of the New York Heart Asociation. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th edn. Boston: Brown & co.;1994. p.253-6.
10. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981; 64:1227-34.
11. Neuropathic Pain Network. http://www.neuropathicpainnetwork.org/english/ index.asp;2004. Accessed 8 February 2008.
12. Torrance N, Smith BH, Bennett M, Lee AJ. The epidemiology of chronic neuropathic pain in the community. Results from a general population survey. J Pain 2006;7:281-9.
13. Jensen SA, Vatten LJ, Myhre HO. The prevalence of chronic critical lower limb ischaemia in a population of 20,000 subjects 40-69 years of age. Eur J Vasc Endovasc Surg 2006;32:69-5.
14. Shaper AG, Cook DG, Walker M, Macfarlane PW. Prevalence of ischaemic heart disease in middle aged British men. Br Heart J 1984; 51:595-605.
15. Breivik H, Collet B, Ventafridda V. Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
16. McDermott A, Toelle TR, Rowbotham DJ, Schefer CP, Dukes E. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006;10:127-35.
17. Goodacre S, Nicholl J, Dixon S, Cross E, Angelini K, Arnold J, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 2004; 328:257.
18. Tengs TO, Lin TH. A meta-analysis of quality of life estimates for stroke. Pharmacoeconomics 2003;21:191-200.
19. Carlsson AM, Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983; 16:87-101.
20. Carlsson AM. Assessment of chronic pain. II. Problems in the selection of relevant questionnaire items for classification of pain and evaluation and prediction of therapeutic effects. Pain 1984; 19:173-84.
21. Cruccu G, Simpson BA, Taylor RS. 56 EFNS guidelines on spinal cord stimulation for neuropathic pain. Eur J Pain 2007;11:22.
22. Attal N, Cruccu G, Haanpaa M. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006:13:1153-69.
23. Farra JT, Young JP Jr, LaMoreaux L. Clinical importance of change in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
24. Melzack, R. Prolonged relief of pain by brief, intense transcutaneous somatic stimulation. Pain 1975;1:357-73.
25. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 1981;15A:221-9.
26. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985; 35:185-188.
27. Jenkinson C, Fitzpatrick R. Measurement of health status in patients with chronic illness: comparison of the Nottingham Health Profile and the General Health Questionnaire. Fam Pract 1990;7:121-4.
28. Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988;27:1411-14.
29. The Euroqol Group. Euroqol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199-208.
30. de Bruin AF, Diederiks JPM, de Witte LP, Stevens FCJ, Philipsen H. The development of a short generic version of the Sickness Impact Profile. J Clin Epidemiol 1994;47:407-18.
31. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
32. Brazier J, Harper R. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
33. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.
34. Marquis P, Fayol C, Joire JE. Clinical validation of a quality of life questionnaire in angina pectoris patients. Eur Heart J 1995; 16:1554-60.
35. British Pain Society and Society of British Neurological Surgeons. Spinal Cord stimulation for the management of pain: recommendations for best clinical practice. London: British Pain Society; 2005.
36. National Statistics. www.statistic.gov.uk/cci/nugget.asp?id=6. Accessed 15 January 2008.
37. Taylor RS. Epidemiology of refractory neuropathic pain. Pain Pract 2006;6:22-26.
38. British Heart Foundation. www.heartstats.org/datapage.asp?id=122. Accessed 15 January 2008.
39. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson T, et al. The problem of chronic refractory angina: report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002;23:355-70.
40. Beard J. ABC of arterial and venous disease: chronic lower limb ischaemia. BMJ 2000;320:854-7.
41. North RB, Shipley J. Practice parameters for them use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med 2007;8:S200-S275.
42. Department of Health. The National Service Framework for long-term conditions. London: Department of Health; 2005.
43. The Royal College of Anaesthetists and The Pain Society (The British Chapter of the International Association for the Study of Pain). Pain management services good practice. London: Royal College of Anaesthetists and The Pain Society; 2003.
44. British Pain Society and Royal College of General Practitioners. A practical guide to the provision of chronic pain services for adults in primary care. London: British Pain Society and Royal College of General Practitioners; 2004.
45. NHS Quality Improvement Scotland. Management of chronic pain in adults. Edinburgh: NHS Quality Improvement Scotland; 2007.
46. International Association for the Study of Pain. Desirable characteristics for pain treatment facilities. Seattle: IASP Press; 2006.
47. Middleton P, Simpson B, Maddern G. Spinal cord stimulation/ neurostimulation: an accelerated systematic review. ASERNIP-S Report No. 43. Adelaide, South Australia: ASERNIP-S; 2003.
48. Cameron, T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg 2004;100:254-67.
49. Taylor RS, Van Buyten J, Buchser E. Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors. Spine 2005;30:152-60.
50. Grabow TS, Tella PK, Raja SN. Spinal cord stimulation for complex regional pain syndrome an evidence-based medicine review of the literature. Clin J Pain 2003;19:371-83.
51. Taylor RS, Van Buyten JP, Buchser E. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain 2006;10:91-101.
52. Turner JA, Loeser JD, Bell KG. Spinal cord stimulation for chronic low back pain: a systematic literature synthesis. Neurosurgery 1995; 37:1088-95.
53. The Information Centre (England). Hospital Episode Statistics - 2005-06. Leeds: The NHS Information Centre; 2007.
54. The Information Centre (England). Hospital Episode Statistics - 2006-07. Leeds: The NHS Information Centre; 2008.
55. Neuromodulation Society of UK and Ireland. Submission to NICE for the Health Technology Appraisal of Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. 2008.
56. Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness; CRD's guidance for those carrying out or commissioning reviews. CRD Report 4, 2nd edn. York: Centre for Reviews and Dissemination; 2001.
57. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998;317:1185-90.
58. Spincemaille GHK. Spinal cord stimulation in patients with critical limb ischemia: a preliminary evaluation of a multicentre trial. Acta Chirurg Aust 2000;32:49-51.
59. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007;132:179-88.
60. Kumar K, North R, Taylor R, Sculpher M, Van den Abeele C, Gehring M, et al. Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study). Neuromodulalion 2005;8:213-18.
61. Milbouw G, Leruth S. Spinal cord stimulation vs conventional medical management: a multicenter randomized controlled trial of patients with failed back surgery syndrome (PROCESS study). Surg Neurol 2007; 68:201.
62. North RB, Kidd DH, Farrokhi E, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized; controlled trial. Neurosurgery 2005;56:98-106.
63. North RB, Kidd DH, Piantadosi S. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a prospective, randomized study design. Acta Neurochirurg Suppl 1995;64:106-8.
64. North RB, Kidd DH, Lee MS, Piantodosi S. A prospective, randomized study of spinal cord stimulation versus reoperation for failed back surgery syndrome: initial results. Stereolac Funct Neurosurg 1994; 62:267-72.
65. Kemler MA, Barendse GA, van Kleef M, de Vet HC, Rijks CP, Furnee CA, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000;343:618-24.
66. Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. Spinal cord stimulation for chronic reflex sympathetic dystrophy - five-year follow-up. N Engl J Med 2006;354:2394-6.
67. Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years' follow-up of the randomized controlled trial. Ann Neurol 2004;55:13-18.
68. Spincemaille GH, Klomp HM, Steyerberg EW, Habbema JD. Pain and quality of life in patients with critical limb ischaemia: results of a randomized controlled multicentre study on the effect of spinal cord stimulation. ESES study group. Eur J Pain 2000;4:173-84.
69. Spincemaille GH, Klomp HM, Steyerberg EW, van Urk H, Habbema JD, ESES Study Group. Technical data and complications of spinal cord stimulation: data from a randomized trial on critical limb ischemia. Stereotac Funct Neurosurg 2000;74:63-72.
70. Klomp HM Spincemaille GH, Steyerberg EW, Habbema JD, van Urk H. Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet 1999;355:1040-4.
71. Ubbink DT, Spincemaille GH, Prins MH, Reneman RS, Jacobs MJ. Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial. J Vasc Surg 1999;30:236-44.
72. Klomp HM, Spincemaille GH, Steyerberg EW, Berger MY, Habbema JD, van Urk H. Design issues of a randomised controlled clinical trial on spinal cord stimulation in critical limb ischaemia. Eur J Vasc Endovasc Surg 1995;10:478-85.
73. Suy R, Gybels J, van Damme H, Martin D, van Maele R, Delaporte C. Spinal cord stimulauon for ischemic rest pain. The Belgian randomized study. In Horsch S, Clayes L, editors. Spinal cord stimulation: an innovative method in the treatment of PVD. Darmstadt: Steinkopff; 1994, pp. 197-202.
74. Jivegard LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg 1995;9:421-5.
75. Claeys LG, Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 1996;15:344-9.
76. Claeys LGY, Horsch S. Spinal cord stimulation (SCS) following intravenous prostaglandin El (PGE 1) therapy in non-reconstructible peripheral vascular disease (PVD): Fontaine stage IV. Pain Clin 1999;11:235-43.
77. Claeys L, Horsch S. Effects of spinal cord stimulation on ischaemic inflammatory pain and wound healing in patients with peripheral arterial occlusive disease. Pain Digest 1997;7:200-3.
78. Claeys LGY. Epidural spinal cord stimulation following intravenous prostaglandin E1 therapy in patients with ischaemic pain (peripheral vascular disease Fontaine stage IV). Preliminary results of a controlled randomized study. Pain Clin 1998;10:165-172.
79. De Jongste MJ, Hautvast RW, Hillege HL, Lie KI. Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris: a prospective, randomized clinical study. Working Group on Neurocardiology. J Am Coll Cardiol 1994;23:1592-7.
80. Mannheimer C, Eliasson T, Augustinsson LE, Blomstrand C. Emanuelsson H, Larsson S et al. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation 1998;97:1157-63.
81. Norrsell H, Pilhall M, Eliasson T, Mannheimer C. Effects of spinal cord stimulation and coronary artery bypass grafting on myocardial ischemia and heart rate variability: further from the ESBY study: Cardiology 2000;94:12-18.
82. Ekre O, Eliasson T, Norrsell H, Wahrborg P, Matmheimer C, Electrical Stimulation versus Coronary Artery Bypass Surgery in Severe Angina Pectoris Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY Study. [see comment]. Eur Heart J 2002;23:1938-45.
83. McNab D, Khan SN, Sharples LD, Ryan JY, Freeman C, Caine N, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. Eur Heart J 2006;27:1048-53.
84. Hautvast RW, DeJongste MJ, Staal MJ, van Gilst WH, Lie KI. Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am Heart J 1998;136:1114-20.
85. Mailis-Gagnon A, Furlan AD, Sandoval JA, Taylor R. Spinal cord stimulation for chronic pain. Cochrane Database Syst Rev 2004;CD003783.
86. Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain 2004;108:137-47.
87. Ubbink DT, Vermeulen H, Spincemaille GH, Gersbach PA, Berg P, Amann W. Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg 2004;91:948-55.
88. Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. [update of Cochrane Database Syst Rev 2003;CD004001; PMID: 12917998]. Cochrane Database Syst Rev 2005;CD004007.
89. Turner JA, Deyb RA, Loeser JD. Spinal cord stimulation: stimulating questions. Pain 2007;132:10-11.
90. Melzack R. The McGill Questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
91. Steedman SM, Middaugh SJ, Kee WG, Carson DS, Harden RN, Miller C. Chronic-pain medications: equivalence levels and method of quantifying usage. Clin J Pain 1992;8:201-14.
92. Jebsen RH, Taylor N, Trieschmann RB, Trotter MJ, Howard LA. An objective and standardized test of hand function. Arch Phys Med Rehab 1969;50:311-19.
93. Kemler MA, De Vet HCW. An objective and standardized test for foot function: normative values and validation in patients with reflex sympathetic dystrophy. Arch Phys Med Rehab 20001; 81:1401-07.
94. Fairbank JC, Pynsent PP, The Oswestry Disability Index. Spine 2000;25:2940-52.
95. Hill J, Timmis A. Exercise tolerance testing. BMJ 2002; 324:1084-7.
96. Andrews FM, Withey SB. Social indicators of well-being. New York: Plenum Press; 1976.
97. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.
98. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-12.
99. Klomp HM, Steyerberg EW, van Urk H, Habbema JD, and ESES Study Group. Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemia. Eur J Vasc Endovasc Surg 2006;31:500-8.
100. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. J Am Med Assoc 1994;271:1609-14.
101. Amann W. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 2003;26:280-6.
102. Ubbink DT, Vermeulen H. Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection. J Pain Sympt Manage 2006;31(Suppl.4):S30-S35.
103. Mannheimer C, Eliasson T, Andersson B, Bergh CH, Augustinsson LE, Emanuelsson H, et al. Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ 1993;307:477-80.
104. Drummond M, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996;313:275-83.
105. Eddy DM. Technology assesment: The role of mathematical modelling. In Mostellar F, editor. Assessing medical technology. Washington: National Academy Press; 1985;:1444-54.
106. Organisation for Economic Co-operation and Development. Purchasing Power Parities. Paris: OECD; 2008.
107. Curtis L, Netten A. A unit costs of health and social care. Canterbury: PSSRU; 2007.
108. Taylor RJ, Taylor RS. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Int J Technol Assess Hlth Care 2005;21:351-8.
109. National Institute for Clinical Excellence Guidelines for manufacturers and sponsors. London: NICE; 2001.
110. National Institute for Clinical Excellence Guide to the methods of technology appraisal (reference no. 515). London: NICE; 2008.
111. Kumar K, Malik S, Demeria D. Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis. Neurosurgery 2002;51:106-15.
112. Department of Health. National Tariff; 2007/08. London: Department of Health 2007.
113. Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery 2006;58:481-96.
114. Fritzell P, Hagg O, Wessberg P, Nordwall A. 2001 Volvo Award Winner in Clinical Studies: lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine 2001;26:2521-34.
115. Livshits A, Rappaport ZH, Livshits V, Gepstein R. Surgical treatment of painful spasticity after spinal cord injury. Spinal Cord 2002; 40:161-6.
116. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF). No. 54, September 2007. London: BMA and RPS; 2007.
117. Kumar K, Wilson JR, Taylor RS, Gupta S. Complications of spinal cord stimulation, suggestions to improve outcome, and financial impact. J Neurosurg spine 2006;5:191-203.
118. Department of Health. National schedule of reference costs 2006-07. London: Department of Health; 2008.
119. Ratcliffe J, Thomas KJ, MacPherson H, Brazier J. A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis. BMJ 2006:333:626.
120. Griffin SC, Barber JA, Manca A, Sculpher MJ, Thompson SG, Buxton MJ, et al. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007;354:624.
121. Bernstein SJ, Laouri M, Hilborne LH, Leape LL, Kahan JO, Park RE, et al. Coronary angiography: a literature review and ratings of appropriateness and necessity. Santa Monica, CA: RAND; 1992.
122. Kemler MA, Barendse GAM, Van Kleef M, de Vet HCW, Rijks CPM, Furnee CA, Van Den Wildenberg FAJM. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med 2000; 343:618-24.
123. Breivik H. Chronic pain and the sympathetic nervous system. Acta Anaesthesiol Scand 1997;Suppl. 110:131-4.
124. Cork RC, Isaac I, Elsharydah A, Alexander L. A comparison of the verbal rating scale and the visual analog scale for pain assessment. Internet J Anesthesiol 2004; 8.URL: www.ispub.com/ostia/index.php ?xmlFilePath=journals/ija/vol8n1/vrs.xml
125. Erdman RAM, Passchier J, Kooijman M, Stronks DL. The Dutch version of the Nottingham Health Profile: investigations of psychometric aspects. Psychol Rep 1993;72:1027-35.
126. van Eijk JTM, Smits A, Meyboom W, Mokkink H, van Son J. Reliability and validity of the Nottingham Health Profile in the Dutch situation (internal report). Nijmegan: NUHI; 1987.
127. de Bruin AF, Buys M, de Witte LP, Diederiks JPM. The Sickness Impact Profile: SIP68, a short generic version: first evaluation of the reliability and reproducibility. J Clin Epidemiol 1994; 47:863-71.
128. Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, Van Kleef M. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type 1: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg 2008;108:292.
129. Manufacturer submission to NICE - Cross industry submission by the Association of British Health care Industries on behalf of Advanced Neuromodulation Systems (a division of St Jude Medical Ltd), Boston Scientific Ltd, and Medtronic Ltd. 2008.
130. De Jongste MJ, Staal MJ. Preliminary results of a randomized study on the clinical efficacy of spinal cord stimulation for refractory severe angina pectoris. Acta Neurochirurg Suppl 1993;58:161-4.
131. Eddicks S, Maier-Hauff K, Schenk M, Muller A, Baumann G, Theres H. Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study. Heart 2007;93:580-90.
132. Di Pede F. Long-term effects of spinal cord. stimulation on myocardial ischemia and heart rate variability: results of a 48-hour ambulatory electrocardiographic monitoring. Ital Heart J 2001;2:690-5.
133. Jessurun GA, DeJongste MJ, Hautvast RW, Tio RA, Brouwer J, van Lelieveld S, et al. Clinical follow-up after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity. Pacing Clin Electrophysiol 1999; 22:1432-9.
134. Lind G, Schechtmann G, Winter J. Meyerson BA, Linderoth B. Baclofen-enhanced spinal cord stimulation and intrathecal baclolen alone for neuropathic pain: long-term outcome of a pilot study. Eur J Pain 2008;12:132-6.
135. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1698-701.
136. Fiume D. Permanent spinal cord stimulation in patients With coronary heart disease. Preliminary data. Acta Neurochir Wien 1994; 129:243-4.